Philips has issued a correction for Trilogy Evo Platform Ventilators, according to the U.S. Food and Drug Administration (FDA).
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...
Philips (NYSE:PHG) has issued corrections for some of its Trilogy Evo ventilator platforms due to multiple issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results